ATRION CORPORATION (ATRI) Stock Fundamental Analysis
NASDAQ:ATRI - Nasdaq - US0499041053 - Common Stock - Currency: USD
We assign a fundamental rating of 5 out of 10 to ATRI. ATRI was compared to 190 industry peers in the Health Care Equipment & Supplies industry. ATRI is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. ATRI has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year ATRI was profitable.
In the past year ATRI had a positive cash flow from operations.
ATRI had positive earnings in each of the past 5 years.
Each year in the past 5 years ATRI had a positive operating cash flow.
1.2 Ratios
The Return On Assets of ATRI (4.82%) is better than 82.72% of its industry peers.
ATRI's Return On Equity of 5.26% is fine compared to the rest of the industry. ATRI outperforms 77.49% of its industry peers.
ATRI's Return On Invested Capital of 5.13% is fine compared to the rest of the industry. ATRI outperforms 78.53% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ATRI is above the industry average of 8.19%.
The 3 year average ROIC (11.35%) for ATRI is well above the current ROIC(5.13%). The reason for the recent decline needs to be investigated.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.82% | ||
| ROE | 5.26% | ||
| ROIC | 5.13% |
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
1.3 Margins
ATRI has a better Profit Margin (6.92%) than 78.53% of its industry peers.
ATRI's Profit Margin has declined in the last couple of years.
With a decent Operating Margin value of 7.93%, ATRI is doing good in the industry, outperforming 75.39% of the companies in the same industry.
ATRI's Operating Margin has declined in the last couple of years.
ATRI has a worse Gross Margin (32.08%) than 72.25% of its industry peers.
ATRI's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 7.93% | ||
| PM (TTM) | 6.92% | ||
| GM | 32.08% |
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so ATRI is still creating some value.
Compared to 1 year ago, ATRI has less shares outstanding
Compared to 5 years ago, ATRI has less shares outstanding
ATRI has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
An Altman-Z score of 25.99 indicates that ATRI is not in any danger for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 25.99, ATRI belongs to the top of the industry, outperforming 95.29% of the companies in the same industry.
There is no outstanding debt for ATRI. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 25.99 |
ROIC/WACC0.59
WACC8.7%
2.3 Liquidity
ATRI has a Current Ratio of 6.80. This indicates that ATRI is financially healthy and has no problem in meeting its short term obligations.
ATRI has a better Current ratio (6.80) than 81.68% of its industry peers.
A Quick Ratio of 2.94 indicates that ATRI has no problem at all paying its short term obligations.
ATRI has a Quick ratio of 2.94. This is in the better half of the industry: ATRI outperforms 61.78% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 6.8 | ||
| Quick Ratio | 2.94 |
3. Growth
3.1 Past
The earnings per share for ATRI have decreased strongly by -53.54% in the last year.
The Earnings Per Share has been decreasing by -9.39% on average over the past years.
ATRI shows a small growth in Revenue. In the last year, the Revenue has grown by 6.00%.
ATRI shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.13% yearly.
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%
3.2 Future
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
4. Valuation
4.1 Price/Earnings Ratio
ATRI is valuated quite expensively with a Price/Earnings ratio of 64.50.
Compared to the rest of the industry, the Price/Earnings ratio of ATRI indicates a somewhat cheap valuation: ATRI is cheaper than 68.06% of the companies listed in the same industry.
ATRI's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 29.63.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.5 | ||
| Fwd PE | N/A |
4.2 Price Multiples
73.82% of the companies in the same industry are more expensive than ATRI, based on the Enterprise Value to EBITDA ratio.
ATRI's Price/Free Cash Flow ratio is rather cheap when compared to the industry. ATRI is cheaper than 84.29% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.25 | ||
| EV/EBITDA | 26.01 |
4.3 Compensation for Growth
ATRI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.91%, ATRI has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 1.67, ATRI pays a better dividend. On top of this ATRI pays more dividend than 96.34% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.27, ATRI has a dividend comparable with the average S&P500 company.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.91% |
5.2 History
On average, the dividend of ATRI grows each year by 10.99%, which is quite nice.
ATRI has paid a dividend for at least 10 years, which is a reliable track record.
ATRI has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)10.99%
Div Incr Years20
Div Non Decr Years20
5.3 Sustainability
123.31% of the earnings are spent on dividend by ATRI. This is not a sustainable payout ratio.
ATRI's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP123.31%
EPS Next 2YN/A
EPS Next 3YN/A
NASDAQ:ATRI (8/20/2024, 8:22:19 PM)
459.92
+0.26 (+0.06%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners1.01%
Inst Owner Change-99.88%
Ins Owners1.03%
Ins Owner Change0%
Market Cap809.46M
Analysts40
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.91% |
Yearly Dividend8.6
Dividend Growth(5Y)10.99%
DP123.31%
Div Incr Years20
Div Non Decr Years20
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 64.5 | ||
| Fwd PE | N/A | ||
| P/S | 4.46 | ||
| P/FCF | 29.25 | ||
| P/OCF | 20.89 | ||
| P/B | 3.39 | ||
| P/tB | 3.55 | ||
| EV/EBITDA | 26.01 |
EPS(TTM)7.13
EY1.55%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)15.73
FCFY3.42%
OCF(TTM)22.02
OCFY4.79%
SpS103.18
BVpS135.72
TBVpS129.62
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.82% | ||
| ROE | 5.26% | ||
| ROCE | 5.93% | ||
| ROIC | 5.13% | ||
| ROICexc | 5.53% | ||
| ROICexgc | 5.81% | ||
| OM | 7.93% | ||
| PM (TTM) | 6.92% | ||
| GM | 32.08% | ||
| FCFM | 15.24% |
ROA(3y)11.02%
ROA(5y)11.82%
ROE(3y)12.05%
ROE(5y)13%
ROIC(3y)11.35%
ROIC(5y)12.04%
ROICexc(3y)13.26%
ROICexc(5y)14.73%
ROICexgc(3y)13.99%
ROICexgc(5y)15.58%
ROCE(3y)13.12%
ROCE(5y)13.92%
ROICexcg growth 3Y-18.15%
ROICexcg growth 5Y-19.86%
ROICexc growth 3Y-17.93%
ROICexc growth 5Y-19.35%
OM growth 3Y-18%
OM growth 5Y-13.39%
PM growth 3Y-19.22%
PM growth 5Y-12.62%
GM growth 3Y-6.34%
GM growth 5Y-4.8%
F-Score6
Asset Turnover0.7
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 70.13% | ||
| Cap/Sales | 6.1% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 128.3% | ||
| Profit Quality | 220.39% | ||
| Current Ratio | 6.8 | ||
| Quick Ratio | 2.94 | ||
| Altman-Z | 25.99 |
F-Score6
WACC8.7%
ROIC/WACC0.59
Cap/Depr(3y)171.65%
Cap/Depr(5y)178.27%
Cap/Sales(3y)13.72%
Cap/Sales(5y)13.84%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.54%
EPS 3Y-14.81%
EPS 5Y-9.39%
EPS Q2Q%-93.89%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)6%
Revenue growth 3Y4.68%
Revenue growth 5Y2.13%
Sales Q2Q%11.25%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-52.38%
EBIT growth 3Y-14.16%
EBIT growth 5Y-11.55%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y60.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-5.73%
OCF growth 3Y-20.1%
OCF growth 5Y-14.29%